Entera Bio (ENTX) Director Malca Yonatan Receives Award

What Happened
Malca Yonatan, a director of Entera Bio Ltd. (ENTX), was granted 22,815 shares on August 7, 2026. The shares were issued at $0.00 (an in-kind award in lieu of cash compensation), so no cash changed hands.

Key Details

• Transaction date: 2026-08-07; Transaction type: Award/Grant (Code A)
• Shares received: 22,815; Per-share price reported: $0.00; Reported cash value: $0
• Footnote: The Board approved the award on August 5, 2026, awarding shares in lieu of cash fees for Q1 and Q2 2026; issuance was conditioned on the Company filing a Form S-8, which was filed on Aug 7, 2026 (per footnote F1).
• Shares owned after the transaction: not specified in the provided filing.
• Filing timeliness: Reported for the same date as the transaction (no late filing indicated).

Context
This is a non-cash compensation award—common for director fees—rather than an open-market buy or a sale. Such awards reflect compensation choices by the company (cash vs. equity) and do not by themselves indicate the director’s personal buying or selling intent.